Senior Director of Translational Medicine and Clinical Pharmacology

Sun Pharma is the world’s fourth largest specialty generics company with presence in Specialty, Generics and Consumer Healthcare products. Supported by more than 40 manufacturing facilities, we provide high-quality medicines, trusted by healthcare professionals and patients, to more than 100 countries across the globe. Over the last two decades, Sun Pharma has established itself as a leading player in the generics market in the U.S., and we are rapidly ramping up our presence in the specialty branded market with a focus on dermatology, ophthalmology and onco-dermatology.

About the Role

Sun is seeking a director/senior director within its Translational Medicine and Clinical Pharmacology group in Princeton, NJ. The director will report to the Vice President of Translational Medicine and Clinical Pharmacology. Translational Medicine in the Development group is responsible for early clinical development of novel therapeutics, working in close collaboration with nonclinical and clinical functional areas across all therapeutic areas within our Development Division.

We are seeking a highly qualified individual with a strong background in basic and/or clinical translational research and a desire to work collaboratively across different functional areas. Success depends on integrity, knowledge, imagination, creativity, skill, diversity, and teamwork. The group fosters an environment of mutual respect, encouragement, and teamwork, offering opportunities to collaborate with talented colleagues globally while developing your career.

Responsibilities

• Serve as a key member of a product development team, providing leadership in designing and executing early clinical development strategy.
• Develop and execute early clinical strategy for novel therapeutics, including authoring initial clinical biomarker plans, early clinical development plans, and clinical pharmacology studies for programs in Phases I through IV of development.
• Ensure safe and timely execution of Phase I studies; collaborate closely with internal and external clinical study support staff and scientists (including discovery research, biostatistics, drug metabolism, modeling and simulation, regulatory affairs, and global clinical trials operations).
• Contribute to the identification of novel targets by partnering with research teams to bring a clinical perspective into target identification and validation, and execute clinical studies to evaluate the relevance of potential targets to human disease.
• Develop biomarker strategies through cross-functional teams that provide line-of-sight from First-in-Human studies through clinical Proof-of-Concept.
• Lead the early clinical development strategy for novel therapy programs from preclinical candidates through initial clinical testing (Phase 1) and clinical Proof-of-Concept (Phase 2).
• Develop and execute clinical pharmacology strategies to support later stages of development from Proof-of-Concept (Phase 2) through worldwide marketing application.